Celgene reduces its 2020 sales guidance to range of $19 billion to $20 billion from its previous forecast of more than $21 billion. Source: BioSpace

During a fireside chat at BIO in San Diego earlier this summer, Daniel Skovronsky confirmed Eli Lilly's commitment to finding an effective therapy for ALZ's disease. Source: BioSpace

Siemens AG is looking to take its Healthineers unit public. Source: BioSpace

Incyte has been at the forefront of the IDO race with its candidate epacadostat. Source: BioSpace

The drug developed by Nogra always seemed like a longshot, but Celgene management talked it up over the years as it advanced. Source: BioSpace

You've probably heard those advertisements for "the power of protein," referring to the addition of enzymes to detergent. Source: BioSpace

Stryker picked up controlling interest in Vexim, a French medical device company that specializes in the minimally invasive treatment of vertebral fractures. Source: BioSpace

Finding a treatment for Sanfilippo Syndrome is a personal matter for the Lysogene team. Source: BioSpace

The former Biogen CEO is making waves at his new venture, Vir Biotechnology. Source: BioSpace

Ablynx announced the price of its U.S. IPO at $17.50. Source: BioSpace